Literature DB >> 21835995

Clinical studies. Trying to reset the clock on type 1 diabetes.

Jennifer Couzin-Frankel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21835995     DOI： 10.1126/science.333.6044.819

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  10 in total

Review 1.  Extracellular matrix components in the pathogenesis of type 1 diabetes.

Authors:  Marika Bogdani; Eva Korpos; Charmaine J Simeonovic; Christopher R Parish; Lydia Sorokin; Thomas N Wight
Journal:  Curr Diab Rep       Date:  2014-12       Impact factor: 4.810

2.  Heparan sulfate and heparanase play key roles in mouse β cell survival and autoimmune diabetes.

Authors:  Andrew F Ziolkowski; Sarah K Popp; Craig Freeman; Christopher R Parish; Charmaine J Simeonovic
Journal:  J Clin Invest       Date:  2011-12-19       Impact factor: 14.808

Review 3.  Advancing animal models of human type 1 diabetes by engraftment of functional human tissues in immunodeficient mice.

Authors:  Michael A Brehm; Alvin C Powers; Leonard D Shultz; Dale L Greiner
Journal:  Cold Spring Harb Perspect Med       Date:  2012-05       Impact factor: 6.915

4.  Unraveling the autoimmune translational research process layer by layer.

Authors:  Richard S Blumberg; Bonnie Dittel; David Hafler; Matthias von Herrath; Frank O Nestle
Journal:  Nat Med       Date:  2012-01-06       Impact factor: 53.440

5.  The tyrphostin agent AG490 prevents and reverses type 1 diabetes in NOD mice.

Authors:  Abdoreza Davoodi-Semiromi; Clive H Wasserfall; Chang Qing Xia; Rhonda M Cooper-DeHoff; Martin Wabitsch; Michael Clare-Salzler; Mark Atkinson
Journal:  PLoS One       Date:  2012-05-14       Impact factor: 3.240

6.  Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells.

Authors:  Yong Zhao; Zhaoshun Jiang; Tingbao Zhao; Mingliang Ye; Chengjin Hu; Zhaohui Yin; Heng Li; Ye Zhang; Yalin Diao; Yunxiang Li; Yingjian Chen; Xiaoming Sun; Mary Beth Fisk; Randal Skidgel; Mark Holterman; Bellur Prabhakar; Theodore Mazzone
Journal:  BMC Med       Date:  2012-01-10       Impact factor: 8.775

7.  Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I/II clinical trial.

Authors:  Yong Zhao; Zhaoshun Jiang; Tingbao Zhao; Mingliang Ye; Chengjin Hu; Huimin Zhou; Zhaohui Yin; Yana Chen; Ye Zhang; Shanfeng Wang; Jie Shen; Hatim Thaker; Summit Jain; Yunxiang Li; Yalin Diao; Yingjian Chen; Xiaoming Sun; Mary Beth Fisk; Heng Li
Journal:  BMC Med       Date:  2013-07-09       Impact factor: 8.775

8.  Platelet-Derived Mitochondria Display Embryonic Stem Cell Markers and Improve Pancreatic Islet β-cell Function in Humans.

Authors:  Yong Zhao; Zhaoshun Jiang; Elias Delgado; Heng Li; Huimin Zhou; Wei Hu; Marcos Perez-Basterrechea; Anna Janostakova; Qidong Tan; Jing Wang; Mao Mao; Zhaohui Yin; Ye Zhang; Ying Li; Quanhai Li; Jing Zhou; Yunxiang Li; Eva Martinez Revuelta; Jose Maria García-Gala; Honglan Wang; Silvia Perez-Lopez; Maria Alvarez-Viejo; Edelmiro Menendez; Thomas Moss; Edward Guindi; Jesus Otero
Journal:  Stem Cells Transl Med       Date:  2017-07-07       Impact factor: 6.940

9.  Variations in rodent models of type 1 diabetes: islet morphology.

Authors:  Lesya Novikova; Irina V Smirnova; Sonia Rawal; Abby L Dotson; Stephen H Benedict; Lisa Stehno-Bittel
Journal:  J Diabetes Res       Date:  2013-05-13       Impact factor: 4.011

10.  Human α1-Antitrypsin Binds to Heat-Shock Protein gp96 and Protects from Endogenous gp96-Mediated Injury In vivo.

Authors:  David E Ochayon; Mark Mizrahi; Galit Shahaf; Boris M Baranovski; Eli C Lewis
Journal:  Front Immunol       Date:  2013-10-28       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.